These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 23160078
21. Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors. Woerner A, Sauvain MJ, Aebi C, Otth M, Bolt IB. Hum Vaccin; 2011 Dec; 7(12):1293-8. PubMed ID: 22185812 [Abstract] [Full Text] [Related]
22. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G, Amendola A, Viganò A, Pariani E, Zappa A, Pogliani L, Giacomet V, Savarino A, Podestà A, Rottoli A, Tanzi E, Zanetti A, Radaelli G. Vaccine; 2007 Sep 17; 25(37-38):6692-8. PubMed ID: 17697730 [Abstract] [Full Text] [Related]
23. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine. van Assen S, Holvast A, Telgt DS, Benne CA, de Haan A, Westra J, Kallenberg CG, Bijl M. Clin Immunol; 2010 Aug 17; 136(2):228-35. PubMed ID: 20421178 [Abstract] [Full Text] [Related]
24. Short communication: immunogenicity of an inactivated influenza vaccine and postvaccination influenza surveillance in HIV-infected and noninfected children and adolescents. Machado AA, Machado CM, Boas LS, Lopes MC, Gouvêa Ade F, Succi RC, Mendoza TR, Kanashiro TM, Machado DM. AIDS Res Hum Retroviruses; 2011 Sep 17; 27(9):999-1003. PubMed ID: 21284525 [Abstract] [Full Text] [Related]
28. Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial. Caldera F, Hillman L, Saha S, Wald A, Grimes I, Zhang Y, Sharpe AR, Reichelderfer M, Hayney MS. Inflamm Bowel Dis; 2020 Mar 04; 26(4):593-602. PubMed ID: 31504526 [Abstract] [Full Text] [Related]
29. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA. Vaccine; 2012 Jan 20; 30(5):879-85. PubMed ID: 22155630 [Abstract] [Full Text] [Related]
32. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? Skowronski DM, Tweed SA, De Serres G. J Infect Dis; 2008 Feb 15; 197(4):490-502. PubMed ID: 18275271 [Abstract] [Full Text] [Related]
33. H1N1 vaccination in pediatric renal transplant patients. Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ. Transplant Proc; 2011 May 15; 43(4):1244-6. PubMed ID: 21620100 [Abstract] [Full Text] [Related]
34. Humoral immune response following seasonal influenza vaccine in islet transplant recipients. Silva M, Humar A, Shapiro AM, Senior P, Hoschler K, Baluch A, Wilson LE, Kumar D. Cell Transplant; 2013 May 15; 22(3):469-76. PubMed ID: 23006439 [Abstract] [Full Text] [Related]
35. Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn. Blanchard-Rohner G, Meier S, Bel M, Combescure C, Othenin-Girard V, Swali RA, Martinez de Tejada B, Siegrist CA. Pediatr Infect Dis J; 2013 Dec 15; 32(12):1374-80. PubMed ID: 24569309 [Abstract] [Full Text] [Related]
36. Immunogenicity of inactivated 2009 H1N1 influenza vaccine in pediatric liver transplant recipients. Torii Y, Kimura H, Ochi N, Kaneko K, Ando H, Kiuchi T, Ito Y. Vaccine; 2011 Jun 06; 29(25):4187-9. PubMed ID: 21513762 [Abstract] [Full Text] [Related]
37. Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies. Metze C, Winkelmann A, Loebermann M, Hecker M, Schweiger B, Reisinger EC, Zettl UK. CNS Neurosci Ther; 2019 Feb 06; 25(2):245-254. PubMed ID: 30044050 [Abstract] [Full Text] [Related]
38. Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector. Simon JK, Carter M, Pasetti MF, Sztein MB, Kotloff KL, Weniger BG, Campbell JD, Levine MM. Vaccine; 2011 Nov 28; 29(51):9544-50. PubMed ID: 21986218 [Abstract] [Full Text] [Related]
39. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D. Vaccine; 2011 Dec 09; 30(1):35-41. PubMed ID: 22063386 [Abstract] [Full Text] [Related]
40. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy. Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR. Vaccine; 2011 Nov 15; 29(49):9209-13. PubMed ID: 21974995 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]